treatment outcomes

Transforming Care in Follicular Lymphoma: Outcomes and Prognostic Insights in the Rituximab Era

By MedXY 09/30/2026

This study analyzes treatment patterns, outcomes, and prognostic factors in 344 patients with transformed follicular lymphoma in the rituximab era, revealing poor event-free survival but moderate overall survival and high relapse rates, guiding future clinical strategies.

news Ophthalmology

Impact of Trabeculectomy versus Medical Therapy on Visual Field and Quality of Life in Advanced Glaucoma: Insights from the TAGS Study

By MedXY 08/24/2026

The TAGS Study shows trabeculectomy slows visual field loss more effectively than medical treatment in advanced glaucoma, yet this did not translate into significant quality-of-life improvements over five years, highlighting limitations in current patient-reported outcome measures.

Clinical Updates Diabetes & Endocrinology news

Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes: A Comprehensive Review

By MedXY 07/03/2026

This review synthesizes evidence linking the 2025 Primary Aldosteronism Severity Classification (PASC) with adrenal venous sampling (AVS) lateralization and treatment outcomes, highlighting its potential to enhance precision in PA management.

news Oncology

Long-Term NSCLC Survivors After Pembrolizumab Show High Survival Rates, Rare Immunotherapy Rechallenge

By MedXY 04/13/2026

A nationwide French cohort study reveals that advanced NSCLC patients completing 2 years of pembrolizumab maintain excellent survival outcomes, with most remaining treatment-free and immunotherapy rechallenge being uncommon.